Gene · 4986
Papers4,507
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,507
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders. | Front Syst Neurosci | 2022 | 36276608 | PubTator, text mining | PubMed |
| Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI. | Front Immunol | 2022 | 36275760 | PubTator, text mining | PubMed |
| Conditional Deletion of KOR (Oprk1) in Kisspeptin Cells Does Not Alter LH Pulses, Puberty, or Fertility in Mice. | Endocrinology | 2022 | 36260530 | PubTator, text mining | PubMed |
| Network pharmacology study on the potential effect mechanism of Chuanzhi Tongluo Capsule in the treatment of cerebral infarction. | Medicine (Baltimore) | 2022 | 36254030 | PubTator, text mining | PubMed |
| Discrete GPCR-triggered endocytic modes enable β-arrestins to flexibly regulate cell signaling. | Elife | 2022 | 36250629 | PubTator, text mining | PubMed |
| Putting on molecular weight: Enabling cryo-EM structure determination of sub-100-kDa proteins. | Curr Res Struct Biol | 2022 | 36248264 | PubTator, text mining | PubMed |
| A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists. | Molecules | 2022 | 36234992 | PubTator, text mining | PubMed |
| Chemoenzymatic Synthesis of Optically Active Ethereal Analog of iso-Moramide-A Novel Potentially Powerful Analgesic †. | Int J Mol Sci | 2022 | 36233106 | PubTator, text mining | PubMed |
| Epigenetic Modulation of Opioid Receptors by Drugs of Abuse. | Int J Mol Sci | 2022 | 36233105 | PubTator, text mining | PubMed |
| The Therapeutic Potential of Naturally Occurring Peptides in Counteracting SH-SY5Y Cells Injury. | Int J Mol Sci | 2022 | 36233079 | PubTator, text mining | PubMed |
| The effect of newly designed dual-channel elastomeric pump for intravenous patient-controlled analgesia after total laparoscopic hysterectomy: a randomized, double-blind, prospective study. | Perioper Med (Lond) | 2022 | 36224646 | PubTator, text mining | PubMed |
| Opioid Antagonists from the Orvinol Series as Potential Reversal Agents for Opioid Overdose. | ACS Chem Neurosci | 2022 | 36223082 | PubTator, text mining | PubMed |
| Morphine-induced changes in the function of microglia and macrophages after acute spinal cord injury. | BMC Neurosci | 2022 | 36217122 | PubTator, text mining | PubMed |
| Morphine disrupts macrophage functions even during HIV infection. | J Leukoc Biol | 2022 | 36205434 | PubTator, text mining | PubMed |
| Difelikefalin, a peripherally restricted KOR (kappa opioid receptor) agonist, produces diuresis through a central KOR pathway. | Pharmacol Res | 2022 | 36202183 | PubTator, text mining | PubMed |
| Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal. | Neuron | 2022 | 36202097 | PubTator, text mining | PubMed |
| Blood levels of T-Cell Receptor Excision Circles (TRECs) provide an index of exposure to traumatic stress in mice and humans. | Transl Psychiatry | 2022 | 36192377 | PubTator, text mining | PubMed |
| A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse. | Eur J Med Chem | 2022 | 36179400 | PubTator, text mining | PubMed |
| Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder. | Adv Drug Alcohol Res | 2022 | 36177442 | PubTator, text mining | PubMed |
| Central administration of human opiorphin alleviates dextran sodium sulfate-induced colitis in mice through activation of the endogenous opioid system. | Front Pharmacol | 2022 | 36176442 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4986/papers?page=38